Showing results (131-140 of 183) with videos related to
Sort By:
Pageof 19
Archives of Gynecology and Obstetrics|February 13, 2020
Value of indocyanine green pelvic lymph node mapping in the surgical approach of cervical cancerThomas Papathemelis, Anton Scharl, Michael Anapolski, et al.Journal of Translational Medicine|August 18, 2020
A novel rabbit derived anti-HER2 antibody with pronounced therapeutic effectiveness on HER2-positive breast cancer cells in vitro and in humanized tumor mice (HTM)Anja Kathrin Wege, Nicole Kirchhammer, Linda Veronique Kazandjian, et al.International Journal of Cancer|May 6, 2011
Humanized tumor mice--a new model to study and manipulate the immune response in advanced cancer therapyAnja K Wege, Wolfgang Ernst, Judith Eckl, et al.Acta Oncologica (Stockholm, Sweden)|April 27, 2021
Comparison of survival outcomes and effects of therapy between subtypes of high-grade endometrial cancer - a population-based studySophia Scharl, Michael Gerken, Tim Sprötge, et al.Journal of Ovarian Research|July 16, 2013
GPER-1 acts as a tumor suppressor in ovarian cancerTanja Ignatov, Saskia Modl, Maike Thulig, et al.Archives of Gynecology and Obstetrics|December 12, 2022
Automated breast ultrasound (ABUS) for intraoperative margin control on surgical specimens in breast conserving surgeryMaria Eleni Hatzipanagiotou, Deborah Huber, Elisa Thede, et al.International Journal of Molecular Sciences|July 13, 2024
HER4 Affects Sensitivity to Tamoxifen and Abemaciclib in Luminal Breast Cancer Cells and Restricts Tumor Growth in MCF-7-Based Humanized Tumor MiceVeruschka Albert, Christina Bruss, Deniz Tümen, et al.Archives of Gynecology and Obstetrics|March 17, 2022
Protein kinase C targeting of luminal (T-47D), luminal/HER2-positive (BT474), and triple negative (HCC1806) breast cancer cells in-vitro with AEB071 (Sotrastaurin) is efficient but mediated by subtype specific molecular effectsVeruschka Albert, Gerhard Piendl, Dali Yousseff, et al.Journal of Cancer Research and Clinical Oncology|March 20, 2019
Impact of nodal status and treatment strategy on overall survival in advanced stage cervical cancerThomas Papathemelis, Stella Knobloch, Michael Gerken, et al.Breast Cancer Research and Treatment|July 17, 2008
Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibitionFrank Köster, Jörg B Engel, Andrew V Schally, et al.Pageof 19